Data / Form D filings / VALENTX INC
VALENTX INC: Form D filings
VALENTX INC, a biotechnology company in Maple Grove, MN, filed 5 Form D notices with the SEC between 2009 and 2019. The latest, on February 19, 2019, reports $2 million sold of a $5.3 million offering to 3 investors.
Find out what VALENTX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6901 E. FISH LAKE ROAD, STE. 118, Maple Grove, MN, 55369
- Phone
- (763) 222-1560
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1220832
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 19, 2019 | New notice | $5,250,000 | $1,971,260 | $3,278,740 | 3 | Feb 1, 2019 | sec.gov |
| Aug 16, 2018 | New notice | Indefinite | $10,271,050 | Indefinite | 32 | Jul 25, 2018 | sec.gov |
| Sep 3, 2015 | Amendment | $7,500,000 | $7,500,000 | $0 | 21 | Jul 15, 2014 | sec.gov |
| Jul 28, 2014 | New notice | $7,500,000 | $4,111,767 | $3,388,233 | 20 | Jul 15, 2014 | sec.gov |
| Aug 27, 2009 | New notice | $20,288,949 | $20,288,949 | $0 | 24 | Aug 18, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Elling Halvorson | Director | |
| Paul LaViolette | Director | |
| Bobby Griffin | Director | |
| Jack Ahrens | Director | |
| Jon St. Germain | Executive Officer, Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Feb 18, 2019 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what VALENTX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.